about
Multivariate approaches for efficient detection of potential metabolites from liquid chromatography/mass spectrometry data.Metabolic fingerprinting of rat urine by LC/MS Part 2. Data pretreatment methods for handling of complex data.COX/mPGES-1/PGE2 pathway depicts an inflammatory-dependent high-risk neuroblastoma subset.Structural and Functional Analysis of Calcium Ion Mediated Binding of 5-Lipoxygenase to NanodiscsLimited effect of anti-rheumatic treatment on 15-prostaglandin dehydrogenase in rheumatoid arthritis synovial tissue.Pulmonary epithelial cancer cells and their exosomes metabolize myeloid cell-derived leukotriene C4 to leukotriene D4.Characterization of a human and murine mPGES-1 inhibitor and comparison to mPGES-1 genetic deletion in mouse models of inflammation.Arg126 and Asp49 Are Essential for the Catalytic Function of Microsomal Prostaglandin E2 Synthase 1 and Ser127 Is NotEffects of mPGES-1 deletion on eicosanoid and fatty acid profiles in mice.Evaluation of urinary prostaglandin E2 metabolite as a biomarker in infants with fever due to viral infection.Impaired vagus-mediated immunosuppression in microsomal prostaglandin E synthase-1 deficient mice.IL-1β/HMGB1 complexes promote The PGE2 biosynthesis pathway in synovial fibroblasts.Multivariate strategy for the sample selection and integration of multi-batch data in metabolomics.NOD2-mediated innate immune signaling regulates the eicosanoids in atherosclerosis.Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma.Metabolic fingerprinting of rat urine by LC/MS Part 1. Analysis by hydrophilic interaction liquid chromatography-electrospray ionization mass spectrometry.Dysregulations in circulating sphingolipids associate with disease activity indices in female patients with systemic lupus erythematosus: a cross-sectional study.Targeted lipidomics analysis identified altered serum lipid profiles in patients with polymyositis and dermatomyositis.Kynurenine pathway is altered in patients with SLE and associated with severe fatigue.TNF-α and plasma albumin as biomarkers of disease activity in systemic lupus erythematosus.Systems biology of SLE: biochemical characterisation of subgroups within sle for improved diagnosis and treatmentCharacterization of a new mPGES-1 inhibitor in rat models of inflammationEnhanced multivariate analysis by correlation scaling and fusion of LC/MS and 1H NMR dataEvaluation of different techniques for data fusion of LC/MS and 1H-NMRMass spectrometry-based analysis of cerebrospinal fluid from arthritis patients-immune-related candidate proteins affected by TNF blocking treatmentTwo subgroups in systemic lupus erythematosus with features of antiphospholipid or Sjögren's syndrome differ in molecular signatures and treatment perspectivesInhibition of mPGES-1 or COX-2 Results in Different Proteomic and Lipidomic Profiles in A549 Lung Cancer Cells.Circulating Levels of Interferon Regulatory Factor-5 Associates With Subgroups of Systemic Lupus Erythematosus Patients.Urinary PGE2 metabolite levels in hospitalised infants with infections compared to age-matched controls
P50
Q30926482-13649B07-447F-45B7-A964-152CC50C5AE0Q31008314-C9FA4E7F-27F9-4781-A093-43E65E3D490AQ35818767-B9AA7512-A993-452D-B52C-459E1D1DAEFEQ35968860-92E0018B-18F2-4361-A952-625841114371Q36246027-7987CF00-9E59-4482-A26C-88953CDDC28AQ38756861-2F0C3827-DA8E-45EE-895B-0BF744F3084BQ39094623-C877779E-0FB7-4BB5-95CE-3DABD48B42DCQ39339935-1A01CD90-48EB-4A8F-BE28-A2D73510A124Q39372346-BA2E1431-1F39-4514-8A19-DA280EFB7643Q40187412-5FAD8A36-2EE5-4FBA-9E2E-F5D0995936E5Q40910337-100CC4A1-5CE3-4B57-B789-4730DB1D24CBQ41394835-4C877178-5979-4C4B-A2AA-48C1E582DE12Q41515229-137392D7-3C69-42B0-97A8-DAD611892AECQ42441647-CD92C022-D82E-4D5F-AF9E-3D7EF1B41D87Q43460633-E676E867-1E59-48F3-BB51-FB4AF96DEC8BQ46718727-DA3598E9-03F1-435C-9F28-ECFE5805D9F5Q47876362-5B3852D3-39E1-4E75-A68A-C03C92441910Q54112905-0EB5CD5E-670C-4D6D-874C-AF150731D4E5Q55035261-723586E5-9B79-4AE0-84B5-960790957F0AQ55379196-6A9911F5-5673-4533-8A4B-F4BABD54173BQ58061664-E709995F-32EA-4C3A-A2C9-1973B7EACF44Q60466866-0F24ACA9-C381-42F4-BBED-1A614A81FF77Q60466872-080CEBDD-7385-42CD-B961-643C8982E115Q60466873-CBB4C892-65AF-44EE-BD6E-352B0C85B405Q64247847-A5129AE1-B624-489A-857A-B4C4DC5F7760Q64250304-FBF922AC-16FE-4819-950C-A2323C468424Q64895040-1A477DFC-122B-4223-9ED1-23ADF76D6115Q64980126-C2788738-2EED-49B9-AA35-E37A68D96A13Q92747383-00499868-95F7-45CD-AA0F-995FD7B8A73B
P50
description
Zweeds onderzoekster
@nl
hulumtuese
@sq
researcher
@en
taighdeoir
@ga
հետազոտող
@hy
name
Helena Idborg
@ast
Helena Idborg
@en
Helena Idborg
@es
Helena Idborg
@ga
Helena Idborg
@nl
Helena Idborg
@sl
Helena Idborg
@sq
type
label
Helena Idborg
@ast
Helena Idborg
@en
Helena Idborg
@es
Helena Idborg
@ga
Helena Idborg
@nl
Helena Idborg
@sl
Helena Idborg
@sq
prefLabel
Helena Idborg
@ast
Helena Idborg
@en
Helena Idborg
@es
Helena Idborg
@ga
Helena Idborg
@nl
Helena Idborg
@sl
Helena Idborg
@sq
P106
P21
P27
P31
P496
0000-0003-4041-4729